We are live on ! Find out more
ED

Exane Derivatives Portfolio holdings

AUM $174M
1-Year Est. Return 7.84%
This Fund
S&P 500
This Quarter Est. Return
+1.06%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
AUM
$355M
AUM Growth
-$58.3M
Cap. Flow
-$51.7M
Cap. Flow %
-14.57%
Top 10 Hldgs %
19.68%
Holding
1,105
New
222
Increased
181
Reduced
330
Closed
90

Top Sells

Rank Stock Value
1
STLA icon
Stellantis
STLA
+$24.9M
2
RACE icon
Ferrari
RACE
+$19.1M
3
CNH
CNH Industrial
CNH
+$12.3M
4
IVE icon
iShares S&P 500 Value ETF
IVE
+$8.23M
5
UBS icon
UBS Group
UBS
+$5.09M

Sector Composition

Rank Sector Weight
1 Technology 16.03%
2 Consumer Discretionary 9.4%
3 Healthcare 9.16%
4 Industrials 8.21%
5 Financials 7.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BCE icon
76
BCE
BCE
$20.8B
$1.11M 0.31%
20,084
-4,950
-20% -$262K
PFE icon
77
Pfizer
PFE
$143B
$1.1M 0.31%
21,316
-819
-4% -$42.5K
BHP icon
78
BHP
BHP
$211B
$1.1M 0.31%
15,932
-34,995
-69% -$2.13M
CARR icon
79
Carrier Global
CARR
$49.4B
$1.1M 0.31%
23,926
+11,408
+91% +$537K
MCHP icon
80
Microchip Technology
MCHP
$38.8B
$1.1M 0.31%
14,605
-871
-6% -$65.6K
GILD icon
81
Gilead Sciences
GILD
$165B
$1.09M 0.31%
18,384
+3,636
+25% +$232K
MET icon
82
MetLife
MET
$62.4B
$1.09M 0.31%
15,442
+2,372
+18% +$160K
CGNX icon
83
Cognex
CGNX
$9.62B
$1.07M 0.3%
13,895
+384
+3% +$26.3K
K
84
DELISTED
Kellanova
K
$1.06M 0.3%
17,516
+2,999
+21% +$180K
TSM icon
85
TSMC
TSM
$1.94T
$1.06M 0.3%
+10,142
New +$1.19M
TLT icon
86
iShares 20+ Year Treasury Bond ETF
TLT
$42.4B
$1.04M 0.29%
7,912
-3,926
-33% -$542K
TMO icon
87
Thermo Fisher Scientific
TMO
$214B
$1.04M 0.29%
+1,766
New +$1.01M
WCC
88
WESCO International
WCC
$15.1B
$1.04M 0.29%
+7,965
New +$998K
RIO icon
89
Rio Tinto
RIO
$152B
$1.04M 0.29%
12,892
-27,563
-68% -$2.09M
PIPP.U
90
DELISTED
Pine Island Acquisition Corp. Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant
PIPP.U
$1M 0.28%
100,395
ETN icon
91
Eaton
ETN
$141B
$1M 0.28%
6,597
+1,386
+27% +$217K
JNJ icon
92
Johnson & Johnson
JNJ
$640B
$1M 0.28%
5,647
-3,810
-40% -$648K
AEP icon
93
American Electric Power
AEP
$70.4B
$994K 0.28%
9,966
+661
+7% +$60.4K
HL icon
94
Hecla Mining
HL
$9.49B
$986K 0.28%
150,037
+79,297
+112% +$459K
PGR icon
95
Progressive
PGR
$128B
$985K 0.28%
8,642
+1,746
+25% +$189K
AAP icon
96
Advance Auto Parts
AAP
$3.53B
$973K 0.27%
4,704
-97
-2% -$21.3K
PEG icon
97
Public Service Enterprise Group
PEG
$38.7B
$958K 0.27%
13,683
+2,764
+25% +$183K
EA icon
98
Electronic Arts
EA
$52.7B
$955K 0.27%
7,553
-787
-9% -$102K
QCOM icon
99
Qualcomm
QCOM
$164B
$949K 0.27%
6,207
+389
+7% +$65.2K
NOACU
100
DELISTED
Natural Order Acquisition Corp. Unit
NOACU
$948K 0.27%
95,000

Similar funds

Exane Derivatives's Q1 2022 Portfolio in Review

As of Q1 2022, Exane Derivatives held 1,105 positions worth $355M, down 14% from $413M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Exane Derivatives withdrew a net $51.7M in Q1 2022, closing 90 positions and reducing 330 holdings. Its most notable exit was iShares S&P 500 Value ETF, an estimated $8.23M position sold in full.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Exane Derivatives opened a new position in Visa worth $4.62M.

  • Exane Derivatives's largest Q1 2022 buy was Visa: 20,811 shares worth $4.62M.
  • Exane Derivatives added most to iShares MSCI China ETF in Q1 2022, an estimated $5.54M increase.
  • Exane Derivatives's biggest Q1 2022 reduction was Stellantis, cutting an estimated $24.9M.
  • Exane Derivatives fully exited iShares S&P 500 Value ETF in Q1 2022, selling an estimated $8.23M.
  • Exane Derivatives's ten largest holdings make up 20% of its $355M portfolio in Q1 2022.
  • Exane Derivatives opened 222 new positions and closed 90 in Q1 2022.
  • Exane Derivatives's portfolio value fell 14% quarter-over-quarter to $355M.

Based on Exane Derivatives's 13F filing for Q1 2022, filed 22 Apr 2022.